United States Regenerative Medicines Sales Market Report 2021

August 2016 | 122 pages | ID: U495B269A94EN
QYResearch

Abstracts

This report studies sales (consumption) of Regenerative Medicines in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Celgene Corporation (U.S.)
• StemCells, Inc. (U.S.)
• Corning Incorporated (U.S.)
• Organogenesis Inc. (U.S.)
• Acelity (KCI Licensing) (U.S.)
• Vertex Pharmaceuticals Incorporated (U.S.)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Cell Therapy
• Gene Therapy
• Immunotherapy
• Tissue Engineering

Split by applications, this report focuses on sales, market share and growth rate of Regenerative Medicines in each application, can be divided into

• Department of orthopedics and musculoskeletal spine
• Skin disease
• Cardiovascular
• Central nervous system
• Oncology
• Diabetes

Contents

United States Regenerative Medicines Sales Market Report 2021

1 REGENERATIVE MEDICINES OVERVIEW

1.1 Product Overview and Scope of Regenerative Medicines
1.2 Classification of Regenerative Medicines
  1.2.1 Cell Therapy
  1.2.2 Gene Therapy
  1.2.3 Immunotherapy
  1.2.4 Tissue Engineering
1.3 Applications of Regenerative Medicines
  1.3.1 Department of orthopedics and musculoskeletal spine
  1.3.2 Skin disease
  1.3.3 Cardiovascular
  1.3.4 Central nervous system
  1.3.5 Oncology
  1.3.6 Diabetes
1.4 USA Market Size (Value and Volume) of Regenerative Medicines (2011-2021)
  1.4.1 USA Regenerative Medicines Sales, Revenue and Price (2011-2021)
  1.4.2 USA Regenerative Medicines Sales and Growth Rate (2011-2021)
  1.4.3 USA Regenerative Medicines Revenue and Growth Rate (2011-2021)

2 USA REGENERATIVE MEDICINES COMPETITION BY MANUFACTURERS

2.1 USA Regenerative Medicines Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Regenerative Medicines Revenue and Share by Manufactures (2015 and 2016)

3 USA REGENERATIVE MEDICINES (VOLUME AND VALUE) BY TYPE

3.1 USA Regenerative Medicines Sales and Market Share by Type (2011-2021)
3.2 USA Regenerative Medicines Revenue and Market Share by Type (2011-2021)

4 USA REGENERATIVE MEDICINES (VOLUME) BY APPLICATION

5 USA REGENERATIVE MEDICINES MANUFACTURERS ANALYSIS

5.1 Celgene Corporation (U.S.)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Regenerative Medicines Product Type and Technology
    5.1.2.1 Cell Therapy
    5.1.2.2 Gene Therapy
  5.1.3 Regenerative Medicines Sales, Revenue, Price of Celgene Corporation (U.S.) (2015 and 2016)
5.2 StemCells, Inc. (U.S.)
  5.2.1 Company Basic Information,Manufacturing Base and Competitors
  5.2.2 Pharmaceuticals Product Type and Technology
    5.2.2.1 Cell Therapy
    5.2.2.2 Gene Therapy
  5.2.3 Pharmaceuticals Sales, Revenue, Price of StemCells, Inc. (U.S.) (2015 and 2016)
5.3 Corning Incorporated (U.S.)
  5.3.1 Company Basic Information,Manufacturing Base and Competitors
  5.3.2 Corning Incorporated (U.S.) Product Type and Technology
    5.3.2.1 Cell Therapy
    5.3.2.2 Gene Therapy
  5.3.3 Corning Incorporated (U.S.) Sales, Revenue, Price of Corning Incorporated (U.S.) (2015 and 2016)
5.4 Organogenesis Inc. (U.S.)
  5.4.1 Company Basic Information,Manufacturing Base and Competitors
  5.4.2 Product Type and Technology
    5.4.2.1 Cell Therapy
    5.4.2.2 Gene Therapy
  5.4.3 Organogenesis Inc. (U.S.) Sales, Revenue, Price of Organogenesis Inc. (U.S.) (2015 and 2016)
5.5 Acelity (KCI Licensing) (U.S.)
  5.5.1 Company Basic Information,Manufacturing Base and Competitors
  5.5.2 Acelity (KCI Licensing) (U.S.) Product Type and Technology
    5.5.2.1 Cell Therapy
    5.5.2.2 Gene Therapy
  5.5.3 Acelity (KCI Licensing) (U.S.) Sales, Revenue, Price of Acelity (KCI Licensing) (U.S.) (2015 and 2016)
5.6 Vertex Pharmaceuticals Incorporated (U.S.)
  5.6.1 Company Basic Information,Manufacturing Base and Competitors
  5.6.2 Vertex Pharmaceuticals Incorporated (U.S.) Product Type and Technology
    5.6.2.1 Cell Therapy
    5.6.2.2 Gene Therapy
  5.6.3 Vertex Pharmaceuticals Incorporated (U.S.) Sales, Revenue, Price of Vertex Pharmaceuticals Incorporated (U.S.) (2015 and 2016)

6 REGENERATIVE MEDICINES TECHNOLOGY AND DEVELOPMENT TREND

6.1 Regenerative Medicines Technology Analysis
6.2 Regenerative Medicines Technology Development Trend

7 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Regenerative Medicines
Table Classification of Regenerative Medicines
Figure USA Sales Market Share of Regenerative Medicines by Type in 2015
Figure Cell Therapy Picture
Figure Gene Therapy Picture
Figure Immunotherapy Picture
Figure Tissue Engineering Picture
Table Applications of Regenerative Medicines
Figure USA Sales Market Share of Regenerative Medicines by Application in 2015
Figure Department of orthopedics and musculoskeletal spine Examples
Figure Skin disease Examples
Figure Cardiovascular Examples
Figure Central nervous system Examples
Figure Oncology Examples
Figure Diabetes Examples
Table USA Regenerative Medicines Sales, Revenue and Price (2011-2021)
Figure USA Regenerative Medicines Sales and Growth Rate (2011-2021)
Figure USA Regenerative Medicines Revenue and Growth Rate (2011-2021)
Table USA Regenerative Medicines Sales of Key Manufacturers (2015 and 2016)
Table USA Regenerative Medicines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Regenerative Medicines Sales Share by Manufacturers
Figure 2016 Regenerative Medicines Sales Share by Manufacturers
Table USA Regenerative Medicines Revenue by Manufacturers (2015 and 2016)
Table USA Regenerative Medicines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Regenerative Medicines Revenue Share by Manufacturers
Table 2016 USA Regenerative Medicines Revenue Share by Manufacturers
Table USA Regenerative Medicines Sales and Market Share by Type (2011-2021)
Table USA Regenerative Medicines Sales Share by Type (2011-2021)
Figure Sales Market Share of Regenerative Medicines by Type (2011-2021)
Figure USA Regenerative Medicines Sales Growth Rate by Type (2011-2021)
Table USA Regenerative Medicines Revenue and Market Share by Type (2011-2021)
Table USA Regenerative Medicines Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Regenerative Medicines by Type (2011-2021)
Figure USA Regenerative Medicines Revenue Growth Rate by Type (2011-2021)
Table USA Regenerative Medicines Sales and Market Share by Application (2011-2021)
Table USA Regenerative Medicines Sales Share by Application (2011-2021)
Figure Sales Market Share of Regenerative Medicines by Application (2011-2021)
Figure USA Regenerative Medicines Sales Growth Rate by Application (2011-2021)
Table Celgene Corporation (U.S.) Basic Information List
Table Regenerative Medicines Sales, Revenue, Price of Celgene Corporation (U.S.) (2015 and 2016)
Table StemCells, Inc. (U.S.) Basic Information List
Table Regenerative Medicines Sales, Revenue, Price of StemCells, Inc. (U.S.) (2015 and 2016)
Table Corning Incorporated (U.S.) Basic Information List
Table Regenerative Medicines Sales, Revenue, Price of Corning Incorporated (U.S.) (2015 and 2016)
Table Organogenesis Inc. (U.S.) Basic Information List
Table Regenerative Medicines Sales, Revenue, Price of Organogenesis Inc. (U.S.) (2015 and 2016)
Table Acelity (KCI Licensing) (U.S.) Basic Information List
Table Regenerative Medicines Sales, Revenue, Price of Acelity (KCI Licensing) (U.S.) (2015 and 2016)
Table Vertex Pharmaceuticals Incorporated (U.S.) Basic Information List
Table Regenerative Medicines Sales, Revenue, Price of Vertex Pharmaceuticals Incorporated (U.S.) (2015 and 2016)